PBM

Propel Bio Management Portfolio holdings

AUM $99.9M
1-Year Est. Return 12.07%
This Quarter Est. Return
1 Year Est. Return
+12.07%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.9M
AUM Growth
+$17.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$6.67M
2
+$4.01M
3
+$2.92M
4
NKTR icon
Nektar Therapeutics
NKTR
+$2.79M
5
JSPR icon
Jasper Therapeutics
JSPR
+$2.45M

Top Sells

1
+$7.45M
2
+$4.35M
3
+$695K
4
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$423K
5
TCRX icon
TScan Therapeutics
TCRX
+$282K

Sector Composition

1 Healthcare 76.77%
2 Energy 23.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAGP icon
1
Plains GP Holdings
PAGP
$3.67B
$23.2M 23.23%
1,272,360
ACHV icon
2
Achieve Life Sciences
ACHV
$259M
$11.9M 11.94%
3,786,425
-2,366,666
AKRO icon
3
Akero Therapeutics
AKRO
$4.47B
$10.9M 10.88%
228,884
MIST icon
4
Milestone Pharmaceuticals
MIST
$229M
$10.2M 10.26%
5,124,890
+3,333,333
APLT icon
5
Applied Therapeutics
APLT
$37.5M
$6.83M 6.83%
11,285,420
PHAT icon
6
Phathom Pharmaceuticals
PHAT
$1.11B
$6.51M 6.51%
552,927
-370,000
ABEO icon
7
Abeona Therapeutics
ABEO
$275M
$5.14M 5.15%
974,022
DCTH icon
8
Delcath Systems
DCTH
$343M
$4.71M 4.72%
438,509
+212,457
CLDX icon
9
Celldex Therapeutics
CLDX
$1.8B
$4.01M 4.01%
+155,000
TCRX icon
10
TScan Therapeutics
TCRX
$63M
$3.52M 3.52%
1,932,304
-154,835
CMPS
11
Compass Pathways
CMPS
$533M
$2.92M 2.93%
+510,000
NKTR icon
12
Nektar Therapeutics
NKTR
$1.33B
$2.79M 2.79%
+49,000
JSPR icon
13
Jasper Therapeutics
JSPR
$51.5M
$2.45M 2.45%
+1,028,806
ZVRA icon
14
Zevra Therapeutics
ZVRA
$475M
$2.21M 2.21%
231,874
VRDN icon
15
Viridian Therapeutics
VRDN
$3.05B
$1.94M 1.94%
+90,000
ATHA icon
16
Athira Pharma
ATHA
$17.2M
$618K 0.62%
149,279
CAPR icon
17
Capricor Therapeutics
CAPR
$245M
– –
-70,000
EIGR
18
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-146,381